| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Michael T Borer last filed a Form 4 in May 2015, as Director at ACAD. Michael T Borer's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Michael T Borer has 2 Form 4 filings on record from January 2015 to May 2015, all as Director at Acadia Pharmaceuticals (ACAD), 2015.
The 6 reported transactions were 4 option exercises, 1 option or other derivative award and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $924K.
The only open-market sale was 27,973 shares of ACAD at an average $33.02 on January 15, 2015, about $924K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2015 | ACAD Acadia Pharmaceuticals Inc | Director | Sale+OE | 27,973 | $33.02 | $923,766.37 | - |